Bariatric surgery and the mechanism of diabetes remission: Are we getting there?

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 11, 2013, Pages 4336-4338

  Haluzík, Martin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; GHRELIN; GLUCAGON LIKE PEPTIDE 1;

ANATOMY; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CALORIC RESTRICTION; CLASSIFICATION; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY BALANCE; EPIDEMIC; FOOD INTAKE; GASTRIC BANDING; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTESTINE ABSORPTION; LAPAROSCOPIC SURGERY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN SECRETION; REMISSION; REVIEW; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GASTROINTESTINAL HORMONES; HUMANS; INSULIN-SECRETING CELLS; MALE; OBESITY, MORBID;

EID: 84887439252     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3698     Document Type: Review

References (20)

1. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 2004;59: 207-223.
2. Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93:S89-S96.
3. Sjöström L, Narbro K, SjöströmCD,et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357: 741-752.
4. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012;379: 2300-2311.
5. Maljaars PW, Peters HP, Mela DJ, Masclee AA. Ileal brake: a sensible food target for appetite control.Areview. Physiol Behav. 2008; 95: 271-281.
6. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab. 2013;98: 4391-4399.
7. Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond). 2009; 33(suppl 1):S33-S40.
8. Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2010;20:1171- 1177.
9. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407: 908-913.
10. Rhee NA, Vilsbøll T, Knop FK. Current evidence for a role of GLP-1 in roux-en-Y gastric bypass-induced remission of type 2 diabetes. Diabetes Obes Metab. 2012;14: 291-298.
11. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244: 741-749.
12. Cohen R, le RouxCW,Papamargaritis D, et al. Role of proximal gut exclusion from food on glucose homeostasis in patients with type 2 diabetes (published online ahead of print June 26, 2013). Diabet Med. doi:10.1111/dme.12268.
13. Jackness C, Karmally W, Febres G, et al. Very low-calorie diet mimics the early beneficial effect of roux-en-Y gastric bypass on insulin sensitivity and β-cell function in type 2 diabetic patients. Diabetes. 2013;62: 3027-3032.
14. Holst JJ, Deacon CF, Vilsbøll T, Krarup T, Madsbad S. Glucagonlike peptide-1, glucose homeostasis and diabetes. Trends Mol Med. 2008;14: 161-168.
15. Pournaras DJ, le Roux CW. Are bile acids the new gut hormones? Lessons from weight loss surgery models. Endocrinology. 2013; 154: 2255-2256.
16. Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153: 3613-3619.
17. Prawitt J, Caron S, Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 2011;11: 160-166.
18. Tomlinson E, Fu L, John L, et al. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology. 2002;143: 1741-1747.
19. Haluzíková D, Lacinová Z, Kaválková P, et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity Silver Spring. 2013; 21: 1335-1342.
20. Sweeney TE, Morton JM. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg. 2013;148: 563-569.